ArticleNature medicine2022
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a).
Michael J Koren et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
117 papers cite itlatest 60 shown
this paperpooled itcites it